Our approach begins by using advanced tools like human genetics to understand the fundamentals of human biology and disease. Understanding the fundamental biological mechanisms of disease is a defining feature of our discovery research efforts. Our discovery programs start with exploring the complex molecular pathways of disease and then to find validate human disease targets. We focus on outcomes that delivering optimal efficacy and safety based on the studies of in vitro and in vivo.
Cell Therapy Research
In this program, we’re developing innovative products that harness a patient’s own immune system to target and attack cancer cells. Understanding our strengths in biologics development, we have formed strategic collaborations including multiple research institutions, which has enabled us to advance the program of chimeric antigen receptor (CAR) and T cell receptor (TCR) product candidates to address both hematological (blood-based) and solid cancers.